Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort. | Cancer Cell Int | 2022 | 36329447 | PubTator, text mining | PubMed |
| All the brain's a stage for serotonin: the forgotten story of serotonin diffusion across cell membranes. | Proc Biol Sci | 2022 | 36321487 | PubTator, text mining | PubMed |
| Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. | Medicine (Baltimore) | 2022 | 36316840 | PubTator, text mining | PubMed |
| A system suitability testing platform for untargeted, high-resolution mass spectrometry. | Front Mol Biosci | 2022 | 36304928 | PubTator, text mining | PubMed |
| Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network. | Contrast Media Mol Imaging | 2022 | 36299828 | PubTator, text mining | PubMed |
| Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma. | Front Genet | 2022 | 36299585 | PubTator, text mining | PubMed |
| Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. | Pharmaceutics | 2022 | 36297437 | PubTator, text mining | PubMed |
| Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B. | Molecules | 2022 | 36296409 | PubTator, text mining | PubMed |
| Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. | J Pers Med | 2022 | 36294746 | PubTator, text mining | PubMed |
| Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. | J Clin Med | 2022 | 36294538 | PubTator, text mining | PubMed |
| Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3. | Biomolecules | 2022 | 36291716 | PubTator, text mining | PubMed |
| Apical Medium Flow Influences the Morphology and Physiology of Human Proximal Tubular Cells in a Microphysiological System. | Bioengineering (Basel) | 2022 | 36290484 | PubTator, text mining | PubMed |
| The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review. | Antibiotics (Basel) | 2022 | 36290068 | PubTator, text mining | PubMed |
| Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients. | Biomedicines | 2022 | 36289808 | PubTator, text mining | PubMed |
| Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models. | Evid Based Complement Alternat Med | 2022 | 36285162 | PubTator, text mining | PubMed |
| Imaging and Editing the Phospholipidome. | Acc Chem Res | 2022 | 36278840 | PubTator, text mining | PubMed |
| Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease. | Front Med (Lausanne) | 2022 | 36275801 | PubTator, text mining | PubMed |
| An update of polycystic ovary syndrome: causes and therapeutics options. | Heliyon | 2022 | 36267367 | PubTator, text mining | PubMed |
| Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality. | Pulm Pharmacol Ther | 2022 | 36265833 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=25